Condition: Lung Cancer · PET-CT · Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
This study aims to synthesise PET data that preserves biological relevance and adds clinical value to the diagnosis and prognosis of lung cancer by establishing anatomical-to-metabolic mapping based on paired diagnostic CT and FDG-PET scans, thereby prospectively validating the clinical utility of the model.
This description comes directly from the study's public registry record.
Xinchen Shen · 17366690957 · shenxinchen9@163.com
Always discuss trial participation with your own doctor first.
| Affiliated Hospital of Zunyi Medical University | Zunyi, Guizhou, China | Recruiting |
| The First Affiliated Hospital of Nanchang University | Jiangxi, Nanchang, China | Recruiting |
| Shanghai East Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
| Shanghai Pulmonary Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
| Ningbo No.2 Hospital | Ningbo, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07243873